Citation Growth Corp. (CSE:CGRO) (OTCQX:CGOTF) is the company that the cannabis industry needs right now. As Rich discussed earlier this month, Citation’s offerings are known for being safe, organic cannabis products that consumers know they can trust.
Today, Rich welcomes Howard Misle, CEO and Director of Citation Growth. Misle was previously CEO and founder of ACC Group of Companies but joined Citation in August of this year. He has been involved in the cannabis sector since 2003 and played an integral role in the Nevada cultivation scene since its legalization.
As CEO of Citation, Misle will oversee all CGRO operations in the United States, and he intends to exponentially grow the company into a top tier competitor in the cannabis space.
Citation Growth Has Incredible Production Capacity and a Superior Product
CGRO is primarily situated in Nevada, though it also has assets in Canada, Washington state, and California.
Earlier today, Citation Growth announced that its approximately 10,000 square foot production facility in northern Las Vegas is fully staffed and trained. All equipment has successfully been installed and tested, and the facility is in full working order.
This is the only facility in Nevada to be triple organic certified, giving Citation the opportunity to realize higher margins on its products.
“We now producing products for the retail market, and at the same time we’re the only triple organic company in the United States,” explains Misle. “And that’s really coming into play right now in regards to the health problems with vape pens.”
The company’s other facility in Nevada, Pahrump, is currently awaiting its organic certification. Once operational, Pahrump will give Citation another 26,500 square feet of certified organic cultivation space. When all of its sites are fully operational, the company will have a total of 569,600 square feet of cultivation and processing ion the state of Nevada.
CGRO’s Remarkable Performance and Key Advantage
While the cannabis industry continues to struggle, CGRO stock has been showing serious growth. This week alone, it’s risen 43%, from $0.30 to $0.43.
One big reason for this is that Citation’s commitment to healthy, organic cannabis products is making it a smart choice for consumers while the vape crisis continues to choke life out of the rest of the industry.
According to Brightfield Group, nearly 50% of cannabis consumers are willing to pay more for premium strains. On top of that, 32% would pay more for certified organic products.
The demand for what Citation Growth is offering has never been higher, as Misle notes.
“The consumer is going to have confidence in what they’re purchasing,” he tells Rich. “[With Citation] it’s as if they’re going to a Whole Foods over a 7-11. You’re getting a product that you know is not going to cause you harm.”
Investors considering CGRO for their next investment will likely want to act fast, as the company has some exciting developments that are likely to push the share price in a positive direction. Specifically, Citation’s DIAMANTE and SUPERIOR product lines will be shipped to dispensaries within the next 21 days.
What do you think? Is Citation Growth the right kind of cannabis company for pot stock investors? Let us know what you think about it in the comments below. Also, be sure to check out Rich’s other interviews with Halo Labs (OCTQX:AGEEF) CEO Kiran Sidhu and Victory Square Technologies Inc. (CSE:VST) (OTCQX:VSQTF) CEO Shafin Tejani.
Featured image: DepositPhotos © OpenRangeStock